scispace - formally typeset
P

Philip L. Lorenzi

Researcher at University of Texas MD Anderson Cancer Center

Publications -  128
Citations -  22127

Philip L. Lorenzi is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 37, co-authored 96 publications receiving 17665 citations. Previous affiliations of Philip L. Lorenzi include University of Michigan & Loyola University Chicago.

Papers
More filters
Journal ArticleDOI

An artifact in LC-MS/MS measurement of glutamine and glutamic acid: in-source cyclization to pyroglutamic acid.

TL;DR: The sensitivity and accuracy of Gln, Glu, and pGlu quantitation by electrospray ionization-based mass spectrometry can be improved dramatically by using chromatographic conditions that adequately separate the three metabolites, isotopic internal standards to correct for in-source pGLU formation, and user-optimized fragmentor voltage for acquisition of the MS spectra.
Journal Article

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2459 more
- 01 Jan 2016 - 
Journal ArticleDOI

A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein.

TL;DR: The substrate specificity suggests that the substrate-binding pocket of BPHL has a hydrophobic acyl binding site which can accommodate the positively charged alpha-amino group, while having an alcohol leaving group binding site that can accommodate nucleoside analogues with a relatively generous spatial allowance.
Journal ArticleDOI

Pancreatic tumor sensitivity to plasma L-asparagine starvation.

TL;DR: Plasma asparagine depletion by RBC-entrapped L-asparaginase in selected patients having no low or no ASNS may be a promising therapeutic approach for pancreatic cancer.